Skip to main content
Premium Trial:

Request an Annual Quote

Spectral Genomics Licenses Affy Patents for Diagnostic Use

NEW YORK, March 2 (GenomeWeb News) - Spectral Genomics of Houston, Texas, said yesterday that it has agreed to license certain Affymetrix patents to manufacture and sell spotted DNA arrays for use in the diagnostics market.

The agreement will commence "once the necessary regulatory approvals of Spectral Genomics' products have been obtained," the company said.

The license agreement covers Spectral Genomics' Constitutional Chip, slated to be introduced in 2004, as well as additional anticipated specialty arrays to be used in cancer diagnostics.

The company already sells these chips as research products under a licensing agreement it signed with Affy in October. The new agreement pertains to Spectral Genomics' plans to seek regulatory approval for these products as diagnostics.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.